Skip to main content
. 2020 Apr 27;10:7052. doi: 10.1038/s41598-020-64017-0

Table 1.

Summary of patient characteristics.

ID Diagnosis Sex Age (year) Cell viability % Allele
HF370 AATD M 68 80 Z
HF371 Organ donor M 6 71 M
HF384 AATD M 5 74 Z
HF395 FAP M 31 82 M
HF399 Organ donor F 40 84 M
HF403 Organ donor M 68 78 M
HF414 Organ donor M 27 82 M
HF423 Colorectal metastasis M 73 79 M
HF424 Colorectal metastasis M 68 67 M
HF425 Cholangiocarcinoma M 73 71 M
HF426 Unknown tumour M 71 80 M
HF433 Colorectal metastasis M 73 66 M
HF435 Colorectal metastasis F 81 66 M
HF440 Organ donor M 63 80 M
HF455 AATD M 0.8 78 Z
HF456 Organ donor M 12 77 M
Diagnosis n (total = 16) Sex
A1ATD 3 (18,8%) Female 2 (12,5%)
Cholangiocarcinoma 1 (6,3%) Male 14 (87,5%)
Colorectal metastasis 4 (25%) Cell isolation (mean)
FAP 1 (6,3%) Age (years) 47,5 (0.8–81)
Organ donor 6 (37,5%) Tissue mass (g) 258,4 (41–584)
Unknown tumour 1 (6,3%) Cell viability (%) 75,9 (66–84)

AATD: Alpha 1-antitrypsin deficiency,

FAP: Familial Amyloidotic Polyneuropathy,

M: male, F: female.